Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep Macrostructure, Cyclic Alternating Pattern and CSF Cytokines in De Novo Relapsing-Remitting Multiple Sclerosis: A Controlled Polysomnographic Study.

Journal of sleep research·2025
Same author

Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.

Journal of neurology·2024
Same author

Muscle atonia index during multiple sleep latency test: A possible marker to differentiate narcolepsy from other hypersomnias.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2023
Same author

Interictal and subclinical ictal discharges emerging from tonic REM sleep in sleep-related hypermotor epilepsy.

Sleep medicine·2022
Same author

Whole-brain white matter network reorganization in HIV.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2021
Same author

The impact of antiseizure medications on polysomnographic parameters: a systematic review and meta-analysis.

Sleep medicine·2021

Related Experiment Video

Updated: May 3, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K

Phlebographic study does not show differences between patients with MS and control subjects.

M Stefanini1, S Fabiano2, F Garaci1

  • 1From the Departments of Diagnostic Imaging (M.S., S.F., F.G., S.M., A.M., V.C., M.F., R.F., R.G., G.S.).

AJNR. American Journal of Neuroradiology
|February 15, 2014
PubMed
Summary
This summary is machine-generated.

This study found no direct link between chronic cerebrospinal venous insufficiency and multiple sclerosis (MS). Venous abnormalities were equally common in both MS patients and healthy individuals, suggesting no causal relationship.

More Related Videos

Non-invasive Assessment of Microvascular and Endothelial Function
05:41

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

15.8K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K

Related Experiment Videos

Last Updated: May 3, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Non-invasive Assessment of Microvascular and Endothelial Function
05:41

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

15.8K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K

Area of Science:

  • Neurology
  • Vascular Imaging
  • Medical Diagnostics

Background:

  • The potential link between chronic cerebrospinal venous insufficiency (CCVI) and multiple sclerosis (MS) is a growing area of interest.
  • Previous studies using echo-color Doppler ultrasonography have yielded inconsistent results.
  • There is a need for more objective diagnostic methods to assess CCVI in MS patients.

Purpose of the Study:

  • To investigate the presence of venous stenoses in the azygos and internal jugular veins using venography in patients with MS.
  • To compare the prevalence of venous abnormalities in MS patients versus healthy controls.

Main Methods:

  • A venography study was conducted on 29 patients with MS and 15 healthy volunteers.
  • Selective catheterization of the ileo-lumbar plexus, azygos, and internal jugular veins was performed.
  • A venous lumen cross-sectional area reduction >50% was defined as significant stenosis; blood pressure was also measured.

Main Results:

  • Significant venous stenosis (>50% area reduction) was detected in 84% of all subjects, with no significant difference between MS patients and controls.
  • Chronic cerebrospinal venous insufficiency patterns were observed in 50% of all participants, irrespective of MS status.
  • Multivariate logistic regression did not reveal a significant association between positive venography findings and MS. Blood pressure differences in stenotic vs. non-stenotic veins were not significant.

Conclusions:

  • The study's findings exclude a direct correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis.
  • Venous abnormalities, including stenosis, were found to be equally prevalent in both MS patients and healthy controls.
  • These results suggest that CCVI is not a direct causative factor or a significant marker for MS.